• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用纵向模型评估当前吸烟者和既往吸烟者的衰老及疾病进展影响。

Estimating effects of aging and disease progression in current and former smokers using longitudinal models.

作者信息

Strand Matthew, Bhatt Surya, Moll Matthew, Baraghoshi David

机构信息

Division of Biostatistics and Bioinformatics, National Jewish Health, Denver, CO, United States.

Department of Biostatistics and Informatics, Colorado School of Public Health, CU Anschutz, Aurora, CO, United States.

出版信息

Glob Epidemiol. 2024 Sep 29;8:100165. doi: 10.1016/j.gloepi.2024.100165. eCollection 2024 Dec.

DOI:10.1016/j.gloepi.2024.100165
PMID:39512808
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11541677/
Abstract

OBJECTIVES

To separate estimates of mean change in a health outcome into components of aging and disease progression for different severity groups of chronic obstructive pulmonary disease (COPD).

STUDY DESIGN AND METHODS

A longitudinal model can be used to estimate mean change in a health outcome over time. Methods to separate this change into portions due to aging and disease progression are discussed, including conditions that allow for accurate estimation. Linear mixed models were used to estimate these changes for   (FEV) for various COPD severity and smoking groups using a large cohort (COPDGene) followed for over 10 years.

RESULTS

Based on an analysis of 4967 subjects, age-related loss in FEV was found to be about 1 % per year, consistent with published work. Excess average losses (those beyond natural aging) were significant for all severity groups (except nonsmokers), including those with smoking history but normal lung function. Subjects in higher severity groups tended to have less loss in FEV, but more relative loss, compared to baseline averages. Losses in FEV that included both aging and disease progression ranged from 1 to 3 % over severity groups, with current smokers generally exhibiting greater mean losses in FEV than former smokers.

DISCUSSION

Effects of disease progression separate from aging can be estimated in observational studies, although care should be taken in order to make sure assumptions involving this separation are reasonable for a given study. This article demonstrates methods to estimate such effects using temporal changes in lung function for subjects in the COPDGene study.

摘要

目的

将慢性阻塞性肺疾病(COPD)不同严重程度组健康结局的平均变化估计值分解为衰老和疾病进展的组成部分。

研究设计与方法

可使用纵向模型来估计健康结局随时间的平均变化。讨论了将这种变化分解为衰老和疾病进展部分的方法,包括允许进行准确估计的条件。使用线性混合模型,对一个大型队列(COPDGene)中随访超过10年的不同COPD严重程度和吸烟组的(第一秒用力呼气容积)(FEV)变化进行估计。

结果

基于对4967名受试者的分析,发现FEV与年龄相关的损失约为每年1%,与已发表的研究结果一致。所有严重程度组(不包括不吸烟者)的额外平均损失(超过自然衰老的损失)都很显著,包括有吸烟史但肺功能正常的人群。与基线平均值相比,严重程度较高组的受试者FEV损失往往较少,但相对损失较大。不同严重程度组中包括衰老和疾病进展的FEV损失范围为1%至3%,当前吸烟者的FEV平均损失通常比既往吸烟者更大。

讨论

在观察性研究中可以估计疾病进展与衰老分开的影响,不过在给定研究中应谨慎确保涉及这种分离的假设是合理的。本文展示了在COPDGene研究中使用受试者肺功能的时间变化来估计此类影响的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ce/11541677/10db051975ce/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ce/11541677/410d69cbd5a0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ce/11541677/10db051975ce/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ce/11541677/410d69cbd5a0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ce/11541677/10db051975ce/gr2.jpg

相似文献

1
Estimating effects of aging and disease progression in current and former smokers using longitudinal models.使用纵向模型评估当前吸烟者和既往吸烟者的衰老及疾病进展影响。
Glob Epidemiol. 2024 Sep 29;8:100165. doi: 10.1016/j.gloepi.2024.100165. eCollection 2024 Dec.
2
10-Year Follow-Up of Lung Function, Respiratory Symptoms, and Functional Capacity in the COPDGene Study.COPDGene 研究中肺功能、呼吸道症状和功能能力的 10 年随访结果。
Ann Am Thorac Soc. 2022 Mar;19(3):381-388. doi: 10.1513/AnnalsATS.202007-873OC.
3
Five-year Progression of Emphysema and Air Trapping at CT in Smokers with and Those without Chronic Obstructive Pulmonary Disease: Results from the COPDGene Study.吸烟者中存在和不存在慢性阻塞性肺疾病(COPD)者的 CT 肺气肿和空气潴留的 5 年进展:来自 COPDGene 研究的结果。
Radiology. 2020 Apr;295(1):218-226. doi: 10.1148/radiol.2020191429. Epub 2020 Feb 4.
4
Predicting COPD Progression in Current and Former Smokers Using a Joint Model for Forced Expiratory Volume in 1 Second and Forced Expiratory Volume in 1 Second to Forced Vital Capacity Ratio.使用一秒用力呼气容积和一秒用力呼气容积与用力肺活量比值的联合模型预测当前吸烟者和既往吸烟者的慢性阻塞性肺疾病进展情况。
Chronic Obstr Pulm Dis. 2022 Jul 29;9(3):439-453. doi: 10.15326/jcopdf.2022.0281.
5
Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.气道黏蛋白 MUC5AC 和 MUC5B 浓度与慢性阻塞性肺疾病的发生和发展:SPIROMICS 队列分析。
Lancet Respir Med. 2021 Nov;9(11):1241-1254. doi: 10.1016/S2213-2600(21)00079-5. Epub 2021 May 28.
6
Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.非吸烟慢性阻塞性肺疾病患者与吸烟慢性阻塞性肺疾病患者的临床特征比较:一项回顾性观察研究。
Int J Chron Obstruct Pulmon Dis. 2014;9:57-63. doi: 10.2147/COPD.S52416. Epub 2014 Jan 8.
7
Emphysema Progression and Lung Function Decline Among Angiotensin Converting Enzyme Inhibitors and Angiotensin-Receptor Blockade Users in the COPDGene Cohort.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂使用者在 COPDGene 队列中肺气肿进展和肺功能下降。
Chest. 2021 Oct;160(4):1245-1254. doi: 10.1016/j.chest.2021.05.007. Epub 2021 May 21.
8
Ratio of FEV/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function.用力肺活量与缓慢肺活量之比<0.7 与肺功能正常的吸烟者阻塞性肺疾病的临床、功能和影像学特征相关。
Chest. 2021 Jul;160(1):94-103. doi: 10.1016/j.chest.2021.01.067. Epub 2021 Feb 1.
9
Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.哥本哈根城市心脏研究中哮喘、慢性阻塞性肺疾病和哮喘-慢性阻塞性肺疾病重叠患者的长期预后:一项前瞻性基于人群的分析。
Lancet Respir Med. 2016 Jun;4(6):454-62. doi: 10.1016/S2213-2600(16)00098-9. Epub 2016 Apr 6.
10
Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.患有和未患有慢性阻塞性肺疾病的吸烟者的急性加重期及肺功能丧失
Am J Respir Crit Care Med. 2017 Feb 1;195(3):324-330. doi: 10.1164/rccm.201605-1014OC.

本文引用的文献

1
10-Year Follow-Up of Lung Function, Respiratory Symptoms, and Functional Capacity in the COPDGene Study.COPDGene 研究中肺功能、呼吸道症状和功能能力的 10 年随访结果。
Ann Am Thorac Soc. 2022 Mar;19(3):381-388. doi: 10.1513/AnnalsATS.202007-873OC.
2
Global Initiative for Chronic Obstructive Lung Disease: The Changes Made.慢性阻塞性肺疾病全球倡议:所做的改变。
Cureus. 2019 Jun 24;11(6):e4985. doi: 10.7759/cureus.4985.
3
Insights about the economic impact of chronic obstructive pulmonary disease readmissions post implementation of the hospital readmission reduction program.
实施医院再入院率降低计划后,对慢性阻塞性肺疾病再入院的经济影响的洞察。
Curr Opin Pulm Med. 2018 Mar;24(2):138-146. doi: 10.1097/MCP.0000000000000454.
4
Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.患有和未患有慢性阻塞性肺疾病的吸烟者的急性加重期及肺功能丧失
Am J Respir Crit Care Med. 2017 Feb 1;195(3):324-330. doi: 10.1164/rccm.201605-1014OC.
5
Occupational exposures and longitudinal lung function decline.职业暴露与肺功能的纵向下降
Am J Ind Med. 2015 Jan;58(1):14-20. doi: 10.1002/ajim.22389. Epub 2014 Nov 10.
6
Age differences in affective and cardiovascular responses to a negative social interaction: the role of goals, appraisals, and emotion regulation.消极社会互动中情感和心血管反应的年龄差异:目标、评估和情绪调节的作用。
Dev Psychol. 2014 Jul;50(7):1919-30. doi: 10.1037/a0036621. Epub 2014 Apr 28.
7
Longitudinal association of C-reactive protein and lung function over 13 years: The EPIC-Norfolk study.13 年间 C 反应蛋白与肺功能的纵向关联:EPIC-诺福克研究。
Am J Epidemiol. 2014 Jan 1;179(1):48-56. doi: 10.1093/aje/kwt208. Epub 2013 Sep 24.
8
Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore Longitudinal Study of Aging.动脉僵硬度的纵向变化轨迹及其与血压的关系:巴尔的摩老龄化纵向研究。
Hypertension. 2013 Nov;62(5):934-41. doi: 10.1161/HYPERTENSIONAHA.113.01445. Epub 2013 Sep 3.
9
Genetic epidemiology of COPD (COPDGene) study design.COPD(COPDGene)遗传流行病学研究设计。
COPD. 2010 Feb;7(1):32-43. doi: 10.3109/15412550903499522.
10
Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease.铍淋巴细胞增殖试验监测可识别临床上有意义的铍病。
Am J Ind Med. 2009 Oct;52(10):762-73. doi: 10.1002/ajim.20736.